Evidence map›Paper›PMID 32231728›Full record

ReviewJournal of Cancer2020

Relationship between Aurora-A V57I Polymorphism and the Risk of Cancer: A Meta-Analysis and Trial Sequential Analysis.

Guangyuan Chen, Cong Hu, Yuxuan Song, Mengxi Xiu, Yiling Zhang, Penghui Lai, Yunyan Li, Xiaoqiang Liu, Peng Huang

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of Cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 3 pooled it
0.6field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 3 syntheses or guidelines pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Journal of breast cancer · 2023
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Guangyuan ChenThe Second Clinical Medical School, Nanchang University, Nanchang, Jiangxi 330006, China.
Cong HuThe Second Clinical Medical School, Nanchang University, Nanchang, Jiangxi 330006, China.
Yuxuan SongDepartment of Urology, Tianjin Medical University General Hospital, Tianjin 300052, China.
Mengxi XiuThe Second Clinical Medical School, Nanchang University, Nanchang, Jiangxi 330006, China.
Yiling ZhangThe Second Clinical Medical School, Nanchang University, Nanchang, Jiangxi 330006, China.
Penghui LaiThe Second Clinical Medical School, Nanchang University, Nanchang, Jiangxi 330006, China.
Yunyan LiThe Second Clinical Medical School, Nanchang University, Nanchang, Jiangxi 330006, China.
Xiaoqiang LiuDepartment of Urology, Tianjin Medical University General Hospital, Tianjin 300052, China.
Peng HuangCenter for Evidence-based Medicine, School of Public Health, Nanchang University, Nanchang 330006, China.
Second Affiliated Hospital of Nanchang University · CNNanchang University · CNTianjin Medical University General Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Aurora-Acancermeta-analysispolymorphism

Identifiers

PMID32231728
PMCPMC7097942
OpenAlexW3012791155

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.